This page is the continuation of patient information in support of Section 8b.
PATIENT INFORMATION
American Cancer Society. Targeted Therapy for breast Cancer. (Retrieved December 11 th 2014): http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-treating-targeted-therapy
Breast Cancer Organization. Aromatose inhibitors. (Retrieved December 11 th 2014): (Retrieved December 11 th 2014): http://www.breastcancer.org/treatment/hormonal/aromatase_inhibitors
Breast Cancer Organization. Kadcyla. (Retrieved December 12 th 2014): http://www.breastcancer.org/treatment/druglist/kadcyla
Breast Cancer Organization. Sentinel Lymph Node Dissection. (Retrieved December 12 th 2014): http://www.breastcancer.org/treatment/surgery/lymph_node_removal/sentinel_dissection
Cancer Research UK. About monoclonal antibodies. (Retrieved December 12 th 2014): https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/targeted-cancer-drugs/types/monoclonal-antibodies
Cancer Research UK. Cetuximab (Erbitux) (Retrieved December 12 th 2014): https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/cetuximab
Cancer Research UK. Everolimus (Afinitor) (Retrieved December 12 th 2014): https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/everolimus
Macmillan Cancer Support UK.Bevacizumab (Avastin®)(Retrieved December 12 th 2014):http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Biologicaltherapies/Monoclonalantibodies/Bevacizumab.aspx
Medline Plus. Tamoxifen. (Retrieved December 11 th 2014): http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682414.html
National Cancer Institute. Hormone Therapy for Breast Cancer. (Retrieved December 11 th 2014): http://www.cancer.gov/cancertopics/factsheet/Therapy/hormone-therapy-breast
National Cancer Institute. FDA Approval for Pertuzumab, Brand name: Perjeta®. (Retrieved December 12 th 2014): http://www.cancer.gov/cancertopics/druginfo/fda-pertuzumab
National Cancer Institute. Sentinel Lymph Node Biopsy. (Retrieved December 12 th 2014): http://www.cancer.gov/cancertopics/factsheet/detection/sentinel-node-biopsy
National Cancer Institute. Lapatinib Ditosylate. (Retrieved December 13 th 2014): http://www.cancer.gov/cancertopics/druginfo/lapatinibditosylate
National Cancer Institute. BRCA1 and BRCA2: Cancer Risk and Genetic Testing. (Retrieved January 25 th 2015): http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
National Comprehensive Cancer Network (NCCN). Guidelines (Retrieved January 25 th 2015):http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
RxList. HERCEPTIN® (trastuzumab) (Retrieved December 11 th 2014): https://www.rxlist.com/herceptin-drug.htm
National Cancer Institute (NCI) Radiation Therapy for Cancer. (Retrieved December 13th 2014): http://www.cancer.gov/cancertopics/factsheet/Therapy/radiation
National Cancer Institute (NCI) Pegylated Liposomal Doxorubicin hydrochloride (Retrieved December 15th 2014): http://www.cancer.gov/drugdictionary?cdrid=39424
National Cancer Institute (NCI) Breast Cancer Treatment: Treatment Option Overview. (Retrieved December 15th 2014): http://www.cancer.gov/cancertopics/pdq/treatment/breast/Patient/page5
The Scott Hamilton CARES initiative (NCI) Paclitaxel Protein-bound Abraxane® (Retrieved December 15th 2014): http://chemocare.com/chemotherapy/drug-info/Paclitaxel-Proteinbound.aspx#.VI6x3CvF9ws
The Scott Hamilton CARES initiative (NCI) Eribulin (Halaven®) (Retrieved December 15th 2014): http://chemocare.com/chemotherapy/drug-info/eribulin.aspx#.VI7fByvF9ws
Wikipedia Anthracycline. (Retrieved December 15th 2014): http://en.wikipedia.org/wiki/Anthracycline
